It’s a common surgeon’s dream: What if you could shrink yourself down, place yourself inside the patient, and fix them from the inside? By combining virtual reality and miniaturized robotics, Vicarious Surgical, with its approach in its name, is looking to do just that.
Although the question of what causes obesity is hotly debated, one theory is gaining traction among researchers who study metabolic diseases: It could be the body’s reaction to inflammation. A team of researchers in Spain pursued that idea—and found evidence that preventing inflammation with drug used to treat heart disease could be an effective strategy.
Scientists use different models to study human disease when it would be too early or ethically problematic to run experiments in humans. Those models aim to mimic human biology as closely as possible to allow more accurate results.
Omada Health adds AI-powered physical therapy platform and a virtual clinic for diabetes, hypertension
Long gone are the days of needing to meet face-to-face with a clinician to get a prescription, view lab results or even complete physical therapy exercises. Now, those tasks can be completed remotely and all in the same place: Omada Health’s digital health platform.
Need to automatically compile data gathered by an insulin pen and send it to a healthcare provider? There’s a device-connected app for that.
For people with diabetes, measuring and taking insulin injections before large meals has always been a pain, both mentally and physically. CeQur aims to tackle both with its long-awaited wearable insulin delivery patch, now heading toward a broader commercial launch with $115 million in venture capital funding.
Nvidia forges trio of AI-based drug discovery partnerships with AstraZeneca, Schrödinger, University of Florida
They say two heads are better than one, but Nvidia is betting four heads might be the best option for supercharging computational drug discovery.
No, you’re not seeing double. The FDA handed out back-to-back 510(k) clearances Monday for a pair of portable devices for wireless patient monitoring.
Sweeping the length of the colon for the subtle signs of cancer can be a difficult task, with polyps hiding among a constantly shifting landscape of folds and shadows. But now the FDA has cleared its first artificial intelligence system for colonoscopy to illuminate lesions the human eye may miss.
Shortly after securing an FDA clearance this year for its transvaginal robotic surgery system, Memic Innovative Surgery has now raised $96 million to kickstart its marketing efforts and scale up manufacturing in the U.S. and abroad.